Holen Sie sich die Stockscreener-App
7.56
1.20%
0.09
Schlusskurs vom Vortag:
$7.47
Offen:
$7.5
24-Stunden-Volumen:
59,106
Relative Volume:
0.17
Marktkapitalisierung:
$446.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.16M
KGV:
-2.0488
EPS:
-3.69
Netto-Cashflow:
$-134.48M
1W Leistung:
-0.26%
1M Leistung:
+0.53%
6M Leistung:
-16.28%
1J Leistung:
-58.05%
1-Tages-Spanne:
$7.50
$7.66
1-Wochen-Bereich:
$7.44
$8.08
52-Wochen-Spanne:
$6.85
$19.89
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Firmenname
Cullinan Therapeutics Inc
Sektor
Branche
Telefon
617-410-4650
Adresse
ONE MAIN STREET, CAMBRIDGE
Vergleichen Sie CGEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
7.55 | 469.64M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
604.40 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.18 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
667.10 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
310.03 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Fortgesetzt | Stifel | Buy |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-05-01 | Eingeleitet | Stifel | Buy |
| 2024-04-15 | Eingeleitet | William Blair | Outperform |
| 2024-02-15 | Eingeleitet | Wedbush | Outperform |
| 2023-06-15 | Eingeleitet | TD Cowen | Outperform |
| 2022-11-21 | Eingeleitet | BTIG Research | Buy |
| 2021-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-02-02 | Eingeleitet | Evercore ISI | Outperform |
| 2021-02-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-02-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-02-01 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cullinan Therapeutics Inc Aktie (CGEM) Neueste Nachrichten
Cullinan Therapeutics Inc. Matches Institutional Buying Filter2025 Price Targets & Short-Term High Return Ideas - beatles.ru
Is Cullinan Therapeutics Inc. meeting your algorithmic filter criteriaTrade Entry Report & Risk Managed Investment Strategies - Newser
Will Cullinan Therapeutics Inc. see short term momentumBond Market & AI Driven Price Forecasts - Newser
Will Cullinan Therapeutics Inc. continue its uptrendOptions Play & Technical Pattern Alert System - Newser
Live market analysis of Cullinan Therapeutics Inc.July 2025 News Drivers & Smart Money Movement Alerts - Newser
What’s the recovery path for long term holders of Cullinan Therapeutics Inc.2025 Volatility Report & Free Weekly Watchlist of Top Performers - Newser
Is it too late to sell Cullinan Therapeutics Inc.Global Markets & Risk Controlled Daily Plans - Newser
When is the best time to exit Cullinan Therapeutics Inc.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser
What high frequency data says about Cullinan Therapeutics Inc.Quarterly Trade Review & Free Community Supported Trade Ideas - Newser
How to build a custom watchlist for Cullinan Therapeutics Inc.Quarterly Trade Summary & Daily Volume Surge Trade Alerts - Newser
Technical signs of recovery in Cullinan Therapeutics Inc.Options Play & High Win Rate Trade Tips - Newser
Applying Elliott Wave Theory to Cullinan Therapeutics Inc.Earnings Recap Report & Low Drawdown Investment Ideas - Newser
Using RSI to spot recovery in Cullinan Therapeutics Inc.Layoff News & Verified Momentum Stock Alerts - Newser
How Cullinan Therapeutics Inc. stock performs during market volatilityJuly 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
Quant Funds Rotate Into Cullinan Therapeutics Inc. StockWeekly Trade Report & Weekly Market Pulse Alerts - 선데이타임즈
Cullinan Therapeutics Inc. Stages Intraday Comeback — Trend ChangeJuly 2025 Final Week & Safe Entry Momentum Stock Tips - classian.co.kr
Using data models to predict Cullinan Therapeutics Inc. stock movementEarnings Summary Report & Fast Moving Trade Plans - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Levels & Weekly High Conviction Ideas - Newser
Market reaction to Cullinan Therapeutics Inc.’s recent news2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Is Cullinan Therapeutics Inc. stock poised for growthEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Is Cullinan Therapeutics Inc. showing signs of accumulationMarket Movement Recap & Technical Entry and Exit Tips - Newser
Does Cullinan Therapeutics Inc. fit your quant trading modelWeekly Trade Summary & AI Optimized Trading Strategy Guides - Newser
Short Interest Drops in Cullinan Therapeutics Inc. After RallyJuly 2025 Recap & Fast Moving Stock Watchlists - metal.it
What is Cullinan Therapeutics Inc.’s book value per shareJuly 2025 Movers & High Accuracy Trade Alerts - 선데이타임즈
How to track smart money flows in Cullinan Therapeutics Inc.July 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Real time social sentiment graph for Cullinan Therapeutics Inc.Market Activity Recap & Weekly Sector Rotation Insights - Newser
Is Cullinan Therapeutics Inc. stock reversal real or fakeGDP Growth & Step-by-Step Trade Execution Guides - Newser
Why Cullinan Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Drop Watch & Long-Term Safe Return Strategies - Newser
How to integrate Cullinan Therapeutics Inc. into portfolio analysis tools2025 Pullback Review & Risk Managed Trade Strategies - Newser
Using Ichimoku Cloud for Cullinan Therapeutics Inc. technicals2025 Momentum Check & Low Drawdown Trading Strategies - Newser
Is Cullinan Therapeutics Inc. exposed to political riskPortfolio Gains Report & Free Expert Approved Momentum Trade Ideas - thegnnews.com
Finanzdaten der Cullinan Therapeutics Inc-Aktie (CGEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cullinan Therapeutics Inc-Aktie (CGEM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| AHMED NADIM | President and CEO |
Feb 25 '25 |
Sale |
8.53 |
12,529 |
106,872 |
430,621 |
| Michaelson Jennifer | Chief Scientific Officer |
Feb 25 '25 |
Sale |
8.53 |
3,756 |
32,039 |
142,004 |
| SUMER JACQUELYN L | Chief Legal Officer |
Feb 25 '25 |
Sale |
8.53 |
3,756 |
32,039 |
136,895 |
| Michaelson Jennifer | Chief Scientific Officer |
Jan 06 '25 |
Sale |
12.51 |
4,000 |
50,040 |
95,760 |
1.17%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):